Newsletter
Home/ News & Events/ Newsletter
News@ESID - September 2022
Dear Colleagues and Friends,
An unusually busy spring and summer are coming to an end. For me, with Autumn, the end of my ESID Presidency comes in view. Allow me to say that it has been a winding road, with COVID, with war on our continent, and with impactful changes in the management of our society. Nevertheless, we have all learned to organize and attend and even to get used to online meetings, and despite the challenges, we have learned that so much more is on the horizon for ESID as a society, in terms of how we can grow, how we can educate, how we can be more involved in research - by providing more grants and fellowships - and how we can have our joint expertise as a society weigh more on guideline development and clinical care, so as to fully stand behind our strategy and mission. Finally, we can, and we should also award more of our members for their outstanding scientific and clinical achievements at mid and late career stages.
News@ESID - April 2022
Dear Members, Colleagues, and Friends,
It’s April 2022 and I am grieved to start another message with the words “Who would have thought?”. Who would have thought that whilst still in a pandemic, we would face a war so close to us? My first message is therefore a call to solidarity with our Ukrainian colleagues, PID patients and other victims, direct and indirect, of this war.
News@ESID - Important Message 2022
Dear Colleagues, Dear Friends,
This was supposed to be a straightforward business message to notify you of a change in the management of our society. However, the war in Ukraine leaves no one untouched and makes the ESID office change a secondary event. We are deeply saddened by these developments.
News@ESID - November 2021
Dear Friends, Dear Colleagues, ESID-members,
I hope you and your family are all well and that you are able to enjoy the beautiful autumn colors or the promise of summer in the southern hemisphere. Despite the unusual circumstances, still preventing us to meet and interact the way we used to, the ESID board and society have been more productive than ever, in many fields. Please read this letter through until the end and discover new opportunities and calls for active participation in the society’s activities.
News@ESID - End of Year , 2020
Dear Friends, Dear Colleagues, ESID-members,
Almost two months have passed since the ESID online meeting. I want to thank you all once again for having contributed to its' success. This is also a good opportunity to remind you that you can still access most of the sessions in the online meeting platform and earn CME credits!
News@ESID - November 2020
Dear Friends, Dear Colleagues, ESID-members,
Three weeks have passed since the ESID online meeting. I want to thank you all for having contributed to its' success. It wouldn't have been possible to create such a lively and interesting meeting if it hadn't been for the time, content, interaction and enthusiasm contributed by each and every single one of you, presenting, chairing, and actively attending.
News@ESID - August 2020
Dear Colleagues, Dear Friends,
August 2020. Soon after I sent the cautiously worded previous newsletter, it became fully clear that having a regular joint ESID-INGID-IPOPI biennial meeting in Birmingham in Autumn was not an option. The board and local committee are giving their best effort to make the online meeting a valuable alternative, in close collaboration with INGID and IPOPI. Don’t hesitate and register. In times of medical challenges it’s even more important to get together and share knowledge and opinions.
News@ESID - December 2019
Dear Friends and Colleagues ESID Members,
Another year has come to its ending. The field of primary immunodeficiencies, or inborn errors of immunity, is still growing at tremendous speed. Despite the advances of improved molecular diagnosis, the clinical management of many primary immunodeficiencies is still extremely challenging. The various WPs within ESID truly are committed to aiding in this challenge as you can learn in the Chairs’ contributions to this Newsletter.
News@ESID - August 2019
Dear Colleagues and Friends,
Time flies and September is approaching. If you took time off, I hope you enjoyed nice and refreshing holidays. With the Focused Meeting in Brusselsliterally around the corner, I welcome you all wholeheartedly, not only for the special focus on malignancy but also because you will get updates on recently described PID as well as some truly exciting unpublished work. Moreover, it is especially nice to welcome you to ESID in Brussels, the city where I was born, in my home country.
